Mr. Dennis Weissman

Area Of Expertise : Lab Compliance
20 Years Of Experience
Training Industry : Life Sciences

Dennis Weissman, A nationally recognized, independent analyst and thought leader in the diagnostic field for over three decades, Dennis is President of Dennis Weissman  & Associates, LLC, Falls Church, VA, a consultancy which provides market intelligence, M&A advisory services, business leadership and public policy advice to diagnostic and life science companies and organizations. He has expertise in Medicare and health care reform policies and trends; clinical lab and pathology payment & compliance policies as well as business trends affecting the diagnostic sector. Dennis founded and served as publisher of Washington G-2 Reports (now G2 Intelligence) through 1999, an information company that reports on and analyzes the U.S. clinical laboratory industry via newsletters, research reports and conferences. Prior to G2, he served as the Director of the Washington Office of the American Society for Medical Technology (now ASCLS) and before that, Special Assistant to the Deputy Assistant Secretary for Health, Department of Health, Education & Welfare (now HHS).

4 results Found
Live Webinar

Adopting Price Controls for U.S. Prescription Drugs: Federal Policy Outlook for 2019 & Beyond

The cost of prescription drugs in the United States remains a hot-button issue for policymakers and consumers alike The vast majority of the public sees drug prices as unreasonably high with one in four people taking prescription drugs r ...

  • Basic & Intermediate & Advanced
  • 60 Mins
  • Feb 27, 2019
Live Webinar

The Healthcare Disruptors: Impact Amazon & Other Big Tech Companies Are Having On Healthcare Industry

Characterized by prohibitive spending, inefficiency, burdensome regulation and increasing frustration among virtually all industry stakeholders, America’s healthcare system has finally reached a tipping point The market forces that have ...

  • Basic & Intermediate & Advanced
  • 60 Mins
  • Mar 28, 2019
Recorded Webinar

How Medicare’s Market-Based Payment System for Laboratory Services Will Change the Industry’s Competitive Dynamics In 2019

Starting in 2018, Medicare reimbursement for most high-volume and many other laboratory tests are seeing reductions of up to 10 percent for each of the next three years, followed by up to 15 percent for each of the next three years as requi ...

  • Intermediate
  • 90 Mins
Recorded Webinar

Where FDA & Congress is Heading in Regulating Laboratory-Developed Tests

This webinar details the history of federal regulation of laboratory-developed tests including requirements under CLIA and FDA’s interpretation of its authority under the Food Drug & Cosmetic Act (FDCA). Key policy pronouncements by the FDA fo ...

  • Basic & Intermediate
  • 60 Mins